{"count":13,"docs":"https://aiswingx.com/docs","items":[{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/RevenueFromContractWithCustomerExcludingAssessedTax","change":0.10180739903981927,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Revenue","label_en":"Revenue","label_ko":"\ub9e4\ucd9c","period_type":"duration","xbrl_tag":"RevenueFromContractWithCustomerExcludingAssessedTax"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/RevenueFromContractWithCustomerExcludingAssessedTax","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-116","unit":"USD","value":7803000000.0,"xbrl_fact_id":"f-116"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-117","unit":"USD","value":7082000000.0,"xbrl_fact_id":"f-117"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Revenue of USD 7,803,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/RevenueFromContractWithCustomerExcludingAssessedTax","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-116"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/OperatingIncomeLoss","change":-5.201293451899757,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Operating income","label_en":"Operating income","label_ko":"\uc601\uc5c5\uc774\uc775","period_type":"duration","xbrl_tag":"OperatingIncomeLoss"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/OperatingIncomeLoss","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-144","unit":"USD","value":-10394000000.0,"xbrl_fact_id":"f-144"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-145","unit":"USD","value":2474000000.0,"xbrl_fact_id":"f-145"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Operating income of USD -10,394,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/OperatingIncomeLoss","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-144"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/NetIncomeLoss","change":-6.355102040816327,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Net income","label_en":"Net income","label_ko":"\uc21c\uc774\uc775","period_type":"duration","xbrl_tag":"NetIncomeLoss"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/NetIncomeLoss","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-164","unit":"USD","value":-10496000000.0,"xbrl_fact_id":"f-164"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-165","unit":"USD","value":1960000000.0,"xbrl_fact_id":"f-165"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Net income of USD -10,496,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/NetIncomeLoss","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-164"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/IncomeTaxExpenseBenefit","change":-0.4829059829059829,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Income tax","label_en":"Income tax","label_ko":"\ubc95\uc778\uc138","period_type":"duration","xbrl_tag":"IncomeTaxExpenseBenefit"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/IncomeTaxExpenseBenefit","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-160","unit":"USD","value":242000000.0,"xbrl_fact_id":"f-160"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-161","unit":"USD","value":468000000.0,"xbrl_fact_id":"f-161"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Income tax of USD 242,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/IncomeTaxExpenseBenefit","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-160"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/ShareBasedCompensation","change":0.03456221198156682,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Stock-based compensation","label_en":"Stock-based compensation","label_ko":"\uc8fc\uc2dd\ubcf4\uc0c1","period_type":"duration","xbrl_tag":"ShareBasedCompensation"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/ShareBasedCompensation","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-355","unit":"USD","value":449000000.0,"xbrl_fact_id":"f-355"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-356","unit":"USD","value":434000000.0,"xbrl_fact_id":"f-356"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Stock-based compensation of USD 449,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/ShareBasedCompensation","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-355"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/NetCashProvidedByUsedInOperatingActivities","change":1.3672600619195046,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Operating cash flow","label_en":"Operating cash flow","label_ko":"\uc601\uc5c5\ud65c\ub3d9 \ud604\uae08\ud750\ub984","period_type":"duration","xbrl_tag":"NetCashProvidedByUsedInOperatingActivities"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/NetCashProvidedByUsedInOperatingActivities","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-379","unit":"USD","value":6117000000.0,"xbrl_fact_id":"f-379"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-380","unit":"USD","value":2584000000.0,"xbrl_fact_id":"f-380"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Operating cash flow of USD 6,117,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/NetCashProvidedByUsedInOperatingActivities","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-379"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/PaymentsToAcquirePropertyPlantAndEquipment","change":0.21800947867298578,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Capex","label_en":"Capex","label_ko":"\uc124\ube44\ud22c\uc790","period_type":"duration","xbrl_tag":"PaymentsToAcquirePropertyPlantAndEquipment"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/PaymentsToAcquirePropertyPlantAndEquipment","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-391","unit":"USD","value":257000000.0,"xbrl_fact_id":"f-391"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-392","unit":"USD","value":211000000.0,"xbrl_fact_id":"f-392"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Capex of USD 257,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/PaymentsToAcquirePropertyPlantAndEquipment","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-391"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/PaymentsForRepurchaseOfCommonStock","change":-0.38424821002386633,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Buybacks","label_en":"Buybacks","label_ko":"\uc790\uc0ac\uc8fc \ub9e4\uc785","period_type":"duration","xbrl_tag":"PaymentsForRepurchaseOfCommonStock"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/PaymentsForRepurchaseOfCommonStock","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-401","unit":"USD","value":774000000.0,"xbrl_fact_id":"f-401"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-402","unit":"USD","value":1257000000.0,"xbrl_fact_id":"f-402"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Buybacks of USD 774,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/PaymentsForRepurchaseOfCommonStock","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-401"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/AccountsReceivableNetCurrent","change":0.02890291064522695,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Accounts receivable","label_en":"Accounts receivable","label_ko":"\ub9e4\ucd9c\ucc44\uad8c","period_type":"instant","xbrl_tag":"AccountsReceivableNetCurrent"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/AccountsReceivableNetCurrent","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-34","unit":"USD","value":5055000000.0,"xbrl_fact_id":"f-34"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-35","unit":"USD","value":4913000000.0,"xbrl_fact_id":"f-35"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Accounts receivable of USD 5,055,000,000 as of 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/AccountsReceivableNetCurrent","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-34"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/InventoryNet","change":0.10090191657271702,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Inventory","label_en":"Inventory","label_ko":"\uc7ac\uace0","period_type":"instant","xbrl_tag":"InventoryNet"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/InventoryNet","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-36","unit":"USD","value":1953000000.0,"xbrl_fact_id":"f-36"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-37","unit":"USD","value":1774000000.0,"xbrl_fact_id":"f-37"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Inventory of USD 1,953,000,000 as of 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/InventoryNet","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-36"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/LongTermDebtNoncurrent","change":0.07695783813095937,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Long-term debt","label_en":"Long-term debt","label_ko":"\uc7a5\uae30\ubd80\ucc44","period_type":"instant","xbrl_tag":"LongTermDebtNoncurrent"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/LongTermDebtNoncurrent","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-66","unit":"USD","value":23832000000.0,"xbrl_fact_id":"f-66"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-67","unit":"USD","value":22129000000.0,"xbrl_fact_id":"f-67"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Long-term debt of USD 23,832,000,000 as of 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/LongTermDebtNoncurrent","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-66"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/Assets","change":-0.16368195449231657,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Total assets","label_en":"Total assets","label_ko":"\ucd1d\uc790\uc0b0","period_type":"instant","xbrl_tag":"Assets"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/Assets","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-54","unit":"USD","value":49362000000.0,"xbrl_fact_id":"f-54"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-55","unit":"USD","value":59023000000.0,"xbrl_fact_id":"f-55"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Total assets of USD 49,362,000,000 as of 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/Assets","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-54"},{"accession":"0000882095-26-000031","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000882095-26-000031/StockholdersEquity","change":-0.4789675373298683,"cik":882095,"company":"GILEAD SCIENCES, INC.","concept":{"label":"Total equity","label_en":"Total equity","label_ko":"\uc790\uae30\uc790\ubcf8","period_type":"instant","xbrl_tag":"StockholdersEquity"},"filed_at":"2026-08-06","filing_index_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/0000882095-26-000031-index.htm","filing_url":"https://aiswingx.com/f/0000882095-26-000031","form":"10-Q","id":"0000882095-26-000031/StockholdersEquity","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-100","unit":"USD","value":11829000000.0,"xbrl_fact_id":"f-100"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-101","unit":"USD","value":22703000000.0,"xbrl_fact_id":"f-101"}],"statement":"GILEAD SCIENCES, INC. (GILD) reported Total equity of USD 11,829,000,000 as of 2026-06-30 in its 10-Q (accession 0000882095-26-000031, filed 2026-08-06).","ticker":"GILD","url":"https://aiswingx.com/n/0000882095-26-000031/StockholdersEquity","verify_url":"https://www.sec.gov/Archives/edgar/data/882095/000088209526000031/gild-20260630.htm#f-100"}],"limit":100,"note":"Inline XBRL facts as filed with the SEC, each with a permanent citation URL and a deep link to the figure in the filing document.","offset":0,"total":13}